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Background: Unsafe injection practices play a major role in elevated rates of morbidity and mortality among
people who inject drugs (IDU). There is growing interest in the direct involvement of IDU in interventions that seek
to address unsafe injecting. This study describes a drug user-led safer injecting education campaign, and explores
facilitators’ experiences delivering educational workshops.
Methods: We conducted semi-structured qualitative interviews with 8 members of the Injection Support (IS) Team
who developed and facilitated a series of safer injecting education workshops. Interviews explored facilitator’s
perceptions of the workshops, experiences being a facilitator, and perspectives on the educational campaign.
Interviews were transcribed verbatim and a thematic analysis was conducted.
Results: IS Team facilitators described how the workshop’s structure and content enabled effective communication
of information about safer injecting practices, while targeting the unsafe practices of workshop participants.
Facilitators’ identity as IDU enhanced their ability to relate to workshop participants and communicate educational
messages in language accessible to workshop participants. Facilitators reported gaining knowledge and skills from
their involvement in the campaign, as well as positive feelings about themselves from the realization that they
were helping people to protect their health. Overall, facilitators felt that this campaign provided IDU with valuable
information, although facilitators also critiqued the campaign and suggested improvements for future efforts.
Conclusions: This study demonstrates the feasibility of involving IDU in educational initiatives targeting unsafe
injecting. Findings illustrate how IDU involvement in prevention activities improves relevance and cultural
appropriateness of interventions while providing individual, social, and professional benefits to those IDU delivering
education.
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Injection drug use is a growing public health concern,
due to the morbidity and mortality observed among
people who inject drugs (IDU) [1-5]. IDU are vulnerable
to an array of health related harms, including but not
limited to HIV, hepatitis C, bacterial and fungal infec-
tions, and venous damage [3,6-9]. Many of these health
harms are the result of unsafe injection practices, which* Correspondence: uhri-tk@cfenet.ubc.ca
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reproduction in any medium, provided the orare preventable given proper preparation and adminis-
tration of drugs by injection.
In response to increased concern for the health and well
being of IDU, a number of intervention and prevention
strategies have been implemented to address the harms
stemming from injection drug use. Most prominent
among these are distribution of sterile syringes and injec-
tion paraphernalia [10-12], harm reduction outreach pro-
grams [13,14], medically supervised injection facilities
[15-17], and educational and behavioural interventions
[18-20]. Educational materials such as posters and pam-
phlets are a mainstay of educational programs, and many
public health initiatives are founded on the assumptionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cedures [21,22]. However, there is a pronounced lack of
evidence-based evaluation of these materials. Despite im-
plementation of all of the aforementioned intervention
and prevention strategies in Vancouver Canada, research
shows that high rates of unsafe injecting persist [23-26].
Given ongoing injection related problems, there is a
growing interest in the involvement of IDU in initiatives
that address unsafe injecting practices and the associated
adverse health consequences and costs. Researchers in
a number of settings internationally have implemented
peer-driven network oriented HIV prevention interven-
tions in which public health experts train peer leaders to
disseminate prevention information and supplies through
micro- and macro- networks of IDU [27-32]. Evaluation
of these approaches highlights several advantages of peers
over traditional outreach methods. Peers are often viewed
as more credible and influential sources of information
[27,28,33], and have the ability to use already established
networks to reach more hidden and diverse populations of
IDU [27,28,33,34]. Furthermore, peers are able to reach
IDU with prevention information and supplies in places
and at times when high-risk behaviours are most likely to
occur [27,28,33], and peer-based education is often more
cost effective than traditional outreach programs [27,28].
Much less is known about the effectiveness of inter-
ventions that have been developed by IDU, which have
emerged from drug-user led efforts to address the harms
associated with unsafe injecting. Although descriptions
of user-led organizations of IDU in Europe and Australia
are available in the literature [35-38], there are few eval-
uations of the educational initiatives developed by these
groups. Evaluations of the Mitsampan Harm Reduction
Centre operated by the Thai Drug Users Network in
Bangkok, Thailand, and programs organized by the
Vancouver Area Network of Drug Users in Vancouver,
Canada, show that these user-led initiatives extend the
reach and effectiveness of harm reduction services
available in these areas [39-43].
Given the remarkable lack of description and evaluation
of user-led approaches to reducing the harms associated
with injection drug use, and complete absence in the
literature of the perspectives of IDU that lead user-led
interventions, we conducted a qualitative exploration
of facilitators’ experiences leading a user-led safer
injecting education campaign.
The VANDU Injection Support Team
The Vancouver Area Network of Drug Users (VANDU)
is active in direct action and advocacy, and has run a
variety of drug user-led programs, including needle
distribution and recovery, an outreach-based alley patrol
program, as well as various action, education, and sup-
port groups [40]. In response to the harms associatedwith assisted and unsafe injection practices, VANDU
expanded their alley patrol program in August 2005 to
develop an ‘Injection Support Team’ (IS Team), which
facilitates education and engagement with large numbers
of IDU. The IS Team is composed of nine current and
former IDU who are recognized as ‘hit doctors’, individ-
uals who are regularly asked to provide assistance with
injections, within the local injecting scene. This group of
individuals initiated the IS Team on a volunteer basis in
response to the ongoing harms associated with unsafe
and assisted injecting, as well as the prohibition on
assisted injections at the supervised injection facility. Fol-
lowing the establishment of the IS Team, a community-
based research project was initiated in partnership
between VANDU, the IS Team, and the British Columbia
Centre for Excellence in HIV/AIDS. The IS Team devel-
oped the following mission statement emphasizing their
basic purpose and activities:
The VANDU IS Team is a user-led program that
provides peer-to-peer education and assistance to
promote safer injecting practices. Through advocacy
and outreach the IS Team seeks to reduce the harms
resulting from unsafe injection and preserve the health
of injection drug users.
Although the IS Team began as an outreach-based
program, there was ongoing interest among the IS Team
members in developing a safer injecting education cur-
riculum that could be delivered in a group setting. When
the IS Team decided to undertake this curriculum devel-
opment process, all IS Team members were invited to
participate, and only one member declined the oppor-
tunity. Curriculum development and workshop facilita-
tion responsibilities were then divided amongst the IS
Team members based on their individual interest and
expertise.
The IS Team education campaign
Utilizing a participatory education approach [44,45]
drawing on research findings, outreach activities, and
community consultation, the IS Team developed a cur-
riculum, training materials, and novel demonstration
processes for five 90 minute workshops promoting safer
injecting practices. The IS Team education campaign
was implemented between November 2009 and April
2010 at five separate locations in Vancouver’s Downtown
Eastside (DTES) including, the VANDU storefront office,
two NGO operated single room occupancy hotels, and
two public drop-in centres.
The first workshop in this campaign described various
unsafe injection practices (e.g., sharing syringes and
other paraphernalia, jugular injections, and assisted in-
jection), provided an overview of the history, training,
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format and content of upcoming workshops. The second
workshop focused on the consequences of unsafe
injecting including, information on how bacteria gets
introduced during the injection process, adulterants and
additives commonly contained in illicit drugs, and
description of the viral infections, venous damage, and
bacterial infections resulting from unsafe injection prac-
tices. This workshop concluded with a discussion of the
locations where participants can access relevant healthcare
services. The third workshop involved step-by-step hands
on demonstrations and practice of injecting skills and
techniques concurrent with a discussion of why each step
is important. Common barriers and challenges to safe
injecting (e.g., lack of supplies, not having a safe place to
inject, and police surveillance and interference) were
discussed, as were strategies that can be used to inject
safely more often. The fourth workshop provided step-by
-step demonstrations on how to correctly prepare various
drugs common in the local context including heroin, co-
caine, crack, methamphetamine, and a range of diverted
pharmaceuticals1 for injection. The final workshop cov-
ered transmission and prevention of HIV and hepatitis C,
attempted to dispel common myths about these diseases,
and provided information about where testing, treatment,
and other services are available.
Each workshop was facilitated by three IS Team mem-
bers. The IS Team education campaign utilized a mixture
of visual learning materials, including PowerPoint slides,
poster sized images, and handouts, to visually communi-
cate step-by-step processes, various symptoms of illnesses,
and modes of disease transmission. In workshops involv-
ing demonstrations, facilitators divided participants into
three smaller groups where they discussed, demonstrated,
and supervised proper technique and procedure for prep-
aration and administration of injections. IS Team mem-
bers’ facilitation style involved a participatory education
approach in which facilitators and workshop participants
engaged as equals and co-learners in the education
process. Drawing on the collective knowledge and experi-
ences of each group, facilitators provided contextually ap-
propriate safer injecting education while using real life
stories and scenarios to stimulate broader discussion of
relevant myths as well as the challenges and barriers to
safer injecting practices. Within workshops, facilitators
aimed to promote mutual support based on shared experi-
ence and equality, while emphasising a harm reduction
approach focused on caring and self-preservation. Facilita-
tors were compensated $20 (CAD) for each workshop and
workshop participants received $3 (CAD) for their partici-
pation. Compensation rates were openly negotiated be-
tween the IS Team members and the VANDU Board of
Directors, and were consistent with the compensation
structure used at VANDU.Methods
This project utilized a community-based research approach
[46,47] involving active collaboration with members of the
IS Team throughout the planning, development, and
implementation of the project. A member of the research
team (CC) attended all planning and development meet-
ings related to the IS Team education campaign, observed
all IS Team education campaign workshops, and actively
sought team member’s opinions and feedback on research
process and emerging themes.
In-depth interviews were conducted with IS Team
members to discuss their perceptions of the workshops
they facilitated, their experiences being a facilitator, and
their perspective on the overall IS Team education cam-
paign. All IS Team members who facilitated education
campaign workshops were invited to participate in an
interview. All interviews lasted between 50 and 80
minutes and were conducted between June and August
2010.
Interviews were facilitated using a semi-structured
topic guide to encourage discussion of how IS Team
members viewed the format and content of the educa-
tion campaign, how this compared to their previous
experiences with safer injecting education, how they per-
ceived their role within the campaign, and perspectives
on facilitating drug user-led safer injecting education.
All interviews were audio-recorded and transcribed
verbatim. A qualitative descriptive methodology was
employed for the analysis of these interviews [48].
Analysis began with a detailed open coding of transcripts
and theoretical memoing in Atlas.ti software, then vali-
dated through systematic review using a constant com-
parative analysis [49,50]. One member of the research
team (CC) was responsible for conducting all interviews
and coding all transcripts. Emergent themes and relevant
excerpts from the interviews were shared and discussed
with all IS Team members to ensure accuracy of
interpretations.
Every IS Team member interviewed provided in-
formed consent to participate, and the study was under-
taken with appropriate ethical approval granted by the
Providence Healthcare/University of British Columbia
Research Ethics Board. IS Team members were compen-
sated for their time in the research interview with a $20
(CAD) honorarium. There were no refusals of the offer
to participate in the interview, and no drop-outs
occurred during the interview process.
Results
In total 340 unique individuals attended IS Team educa-
tion workshops, including 157 (46%) women, 177 (52%)
men, and 6 (2%) transgendered individuals. IS Team
members who participated in qualitative interviews in-
cluded 3 females and 5 males. The median age of IS
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Team included a mix of Caucasian and Aboriginal mem-
bers as to reflect the demographic of the local drug
using population. One of the nine IS Team members
was not asked to participate because he withdrew from
the team early in the development phase of this educa-
tion campaign. Representative excerpts from the qualita-
tive interviews are presented below in order to illustrate
the central themes that emerged in the analysis. Consid-
erable overlap was observed across thematic areas.
Format and content of IS Team educational workshops -
‘it taught the nitty gritty of what you’re doing’
IS Team facilitators described a number of aspects of
this education campaign that contributed to their ability
to communicate information about safer injecting prac-
tices while identifying and addressing the unsafe prac-
tices of workshop participants. Facilitators expressed
that an important aspect of the curriculum was that it
went beyond the mechanics of safe injection, to describe
why each step is important, and the consequences that
can arise from incorrect implementation.
That’s why our workshops were so successful, because
it taught the nitty gritty of what you’re doing and what
you’re doing wrong . . . tell ‘em why it’s not right you
know, and make it so the right thing fits into their
ritual. Not to stop doing it, but make it fit into their
ritual. (Female Facilitator #1)
The participatory and interactive nature of these work-
shops was seen as a critical factor in engaging partici-
pants. This enabled discussion of the realities of
individual’s injecting rituals, the context in which they
use, and the strategies that can be implemented to im-
prove injecting practices.
You could tell some people got really jazzed when they
were talking about personal experiences and stuff.
Which I thought was a really good thing . . . because
people’s own experiences, that’s what it’s all about
right? . . . Cause we’re talking about it from a, this is
the way it should be, not necessarily the way it is, and
they’re talking about it from the way it is. So I think it
was really important. (Male Facilitator #2)
An example of a common barrier to enacting risk re-
duction practices frequently identified within workshops
was the inability to access sterile cookers necessary to
correctly prepare drugs for injection. IS Team facilitators
emphasized the importance of always mixing and filter-
ing drugs prior to injection, and a common solution they
proposed was to carry a metal spoon or use the
concaved bottom of a beverage can for mixing, whilealways being sure to disinfect the preparation surface
with an alcohol swab.
Most facilitators reported that facilitating with two
other IS Team members was a strength of the education
format. Working in groups of three created structure
among facilitators, while allowing them to educate based
on their topics of expertise, and enhancing opportunities
to incorporate stories with their explanations.
I was the more structured one and he was the more off
the cuff type of guy. Like when questions came up and
stuff he had more information because of his
experience. (Male Facilitator #2)
The use of various forms of education materials and dif-
ferent teaching styles were described as major strengths of
the campaign because it engaged a wide range of partici-
pants with different learning needs. It is notable that the
images utilized were described as particularly useful for
communicating the severity of the consequences of unsafe
injecting, and assisted facilitators in maintaining their
focus when interacting with workshop participants.
The shock value of the pictures and then being able to
note how not to let that happen to yourself, it was
really good . . . it also gave us something to focus on . . .
if we got lost on something we could just turn to the
pictures. (Female Facilitator #1)
Shared identity of facilitators and participants - ‘in the
same sort of head space’
All IS Team facilitators expressed that their knowledge
and experience as IDU fostered a sense of shared iden-
tity and equality with workshop participants, which en-
couraged trust and rapport. This also allowed them to
present safer injecting information with examples and
language that was appropriate and easy to understand.
The people that were facilitating it and the people
that were the members, they’re more or less on the
same level. So you could understand, [you] don’t have
to ask questions or why they didn’t get that, you just
know right. Cause you’re both in the same sort of head
space, you’re street people right. (Male Facilitator #3)
Many facilitators described their familiarity with work-
shop participants as increasing their credibility and mak-
ing participants more comfortable asking questions or
sharing information.
I sound like I’m just talking with buddies cause I’m
just sitting there talking to people that I know . . . And
there’s the other part of it, I’m not at the front of the
room because I’m more important than you, I’m just
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kick in when you can cause you guys want answers as
do we, and I’m trying to draw them out and get them
to participate. (Male Facilitator #6)
Facilitators identified how having IDU as facilitators
minimized power dynamics that frequently exist between
educators and learners. Facilitators expressed that their
approach differed from their previous experiences re-
ceiving safer injecting information.
We’re them, it’s not like we’re gonna preach to them
. . . Most of them [formal educators] kind of seem older
or else like they’re trying to talk at them, talk down to
them. It’s more of a classroom type way they talk
instead of talking like friends or drug users talk to
each other, the same way we’re talking . . . You can
pick up more that way cause you don’t feel like you’re
being lectured to. (Male Facilitator #4)
Facilitator’s personal gains - ‘it was a really good
experience for me’
IS Team facilitators articulated various personal gains
from their involvement with the campaign, as most
expressed that facilitating these workshops improved
their overall confidence and public speaking skills. Facili-
tators also expressed that workshops enhanced interper-
sonal social skills and network connections, as well as
changing their attitude towards dealing with other orga-
nizations and professionals.
I’d gotten into pretty much a mode where I’d just hang
out by myself so I didn’t really talk to anybody. This
. . . got me back on meeting people, and talking to
people, and realizing the common ground with other
people in the community. (Male Facilitator #7)I have developed a more professional attitude when
dealing with professionals. I’m more polite, courteous,
well-spoken, time to listen. I’ll do everything but wear
the tie and nametag. (Male Facilitator #6)
Facilitators also described the positive feelings they
gained from the realization that they were making a dif-
ference by helping people to protect their health.
The idea of imparting knowledge to people that is
hopefully going to do something positive for them, I
mean, what’s better than that . . . Especially when you
know there’s a need for it. . . . Like I said, when I first
got into it, it was just for the financial thing, but once
I got into it, knowing that you’re actually making a
difference, that you might actually help someone orsomething, that’s a good feeling. I’ve never done that
type of thing, so it was a really good experience for me.
(Male Facilitator #2)
A few facilitators reported the added benefit of making
changes to their own injecting practices based on infor-
mation they learned through the development and im-
plementation of the campaign. For example, facilitators
reported using alcohol swabs and ties more consistently
and avoiding the re-use of their own syringes.Campaign impact - ‘it works . . . it’s better’
IS Team facilitators overwhelmingly felt that this cam-
paign provided participants with valuable safer injecting
information, some of which including information on
prevention of bacterial infections and how to correctly
prepare various drugs for injection, is not currently
available anywhere else. Most facilitators articulated that
educational workshops not only change injection prac-
tices, but also have the added benefit of connecting IDU
with VANDU and other health services.
I hear it from people every day. Every day somebody
comes up to me and says something. Oh, I tried this,
I tried that. It works, it works, it’s better. Can I go to
treatment? Where do I go to treatment? You know just
questions that were all brought up from those
workshops. And it brought a lot of people to VANDU.
(Female Facilitator #1)
Although all IS Team facilitators spoke of the value of
providing IDU with accurate information about prepar-
ation and administration of injections, they also empha-
sized numerous contextual barriers and challenges that
can make injecting safely difficult. Most commonly,
facilitators identified not having a safe place to inject
and fear of the police as the predominant contextual
factors that can make it difficult to implement safer
injecting knowledge.
If people don’t have a home, if they don’t have a sterile
place, if they’re forced to try to hide in a back alley, or
in a bush, or some other place where they can’t be
found cause they’re so scared of cops. How do you
expect any part of that to be clean or safe?
(Female Facilitator #8)
Given the limits of education in addressing contextual
factors that perpetuate unsafe injecting, facilitators artic-
ulated a desire to expand and improve their activities to
pursue broader change beyond education. Their sugges-
tions predominately focused around opening a user-led fa-
cility and further expanding their outreach activities.
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people could come to get assisted injection and have a
coffee, you know stuff like that . . . A safe [inhalation]
site, a safe injection site, that’s not run by government
frigging employees. (Male Facilitator #7)
Numerous facilitators suggested that it would be benefi-
cial to expand their outreach activities beyond provision
of harm reduction supplies and safer injecting education
to assist with finding housing, provision of lifeskills, assist-
ance finding employment, and support in accessing
healthcare and addictions services.
Criticisms and suggestions - ‘I wanted to do more’
Criticisms of the campaign varied from facilitator to facilita-
tor based on their experiences and the specific workshops
they facilitated. A number of the facilitators identified other
facilitators arriving at workshops sick, or not showing up,
as major issues that impacted the rest of the facilitator’s
ability to properly cover workshop curriculum.
Sometimes she would be sick when she came in, and
she wasn’t very together, so that’s when I’d have to
prolong the workshop I was doing.
(Female Facilitator #1)A few people didn’t show up to do it . . . they’d go and
do something else. (Male Facilitator #7)
A couple facilitators also indicated that sharing of mis-
information was a problem that sometimes occurred
during workshops when facilitators deviated from facts
to opinions.
She was giving her own personal opinion on things
that weren’t actually proven to be true and we don’t
wanna give that kind of information out.
(Female Facilitator #1)
Although facilitators spent a significant amount of time
developing workshop curriculum, no time was spent prior
to the implementation of the campaign developing the fa-
cilitation skills of the IS Team members. A few facilitators
noted that managing a large group of IDU can be difficult,
and that they would have benefited from more time spent
developing facilitation skills before starting the campaign.
I’d of had better preparation for the facilitators . . .
maybe it would be a practice class. I don’t know how
to solve the problem. (Male Facilitator #6)
Facilitators noted that information on overdoses was
missing from the curriculum and could have been added
to strengthen the overall campaign.I wanted to do more things to let people know to give
mouth-to-mouth if your buddy goes down [overdoses]
in a hotel room. Cause through Christmas time we lost
a few people just because they didn’t breathe. Nobody
gave them mouth-to-mouth. (Female Facilitator #5)
Culture and gender specific issues were also identified
as important types of information that were missing
from the curriculum. While information regarding issues
commonly experienced by female injectors (e.g., assisted
injection) was included in the workshops, some felt that
it would be beneficial to incorporate increased emphasis
on particular elements to better address gender-specific
educational needs.
There’s issues that women deal with that are different
from men. Like maybe they don’t know how to inject
because they’ve always been hit [injected] by their
boyfriend . . . With the women you can have
information based on jugging [injecting into the
jugular vein] and why this is more common . . . more
information on the different reasons people use, you
know women are more affected by emotional things,
we could talk about that. (Female Facilitator #8)
Similarly, this facilitator suggested that these work-
shops might have had a greater impact on Aboriginal
IDU if specific information was included on the high
rates of injecting related morbidity among this sub-
population.
I think you could stress what huge a problem this is
for the Aboriginal community . . . maybe they’re not
aware of how serious and how terrible a thing this is
. . . and maybe by educating them they would become
more concerned and maybe it would change things.
(Female Facilitator #8)
One of the facilitators of the HIV and hepatitis C
workshop felt that they were not fully prepared to re-
spond in-depth to participants’ questions about these
diseases and treatments available.
It should’ve been two workshops. One on hep C and
one on HIV because I don’t know all that much about
HIV . . . And maybe a nurse with it because there’s lots
of HIV facts and stuff that you need a nurse to tell you
about, your medications and stuff, that I just wasn’t
prepared for. (Female Facilitator #1)
Facilitators of this particular workshop felt that it
could have been improved by incorporating the technical
expertise of a professional educator alongside IS Team
members.
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In this study, facilitators described how aspects of IS
Team workshop structure and content, including the
participatory approach, facilitating in groups, and the
variety of educational materials used, helped facilitators
communicate information about safer injecting practices
while addressing the realities of participant’s injecting
rituals. Facilitators felt that their knowledge and experi-
ence as IDU increased their credibility and allowed them
to communicate with workshop participants in clear and
understandable ways. Most IS Team facilitators reported
gaining knowledge, skills, and positive feelings about
themselves from their involvement in this education
campaign. Overall, facilitators felt that this campaign
provided IDU with valuable and necessary safer injecting
information, however facilitators also provided criticisms
and suggestions for future improvement.
The findings that facilitators’ experiences as IDU in-
creased their credibility as educators is consistent with
other studies demonstrating that knowledge from per-
sonal experience and trust are important aspects of peer
interventions, which contribute to greater credibility and
influence over behaviour change [27,33,37,40]. Given
considerable local variation among cultures and histories
of IDU, researchers have argued that successful interven-
tions targeting this population need to involve IDU with
extensive knowledge and local experience [40,51]. Previ-
ous research on interventions involving IDU as educators
and outreach workers suggests that these individuals have
the most knowledge and best information about the expe-
riences and current practices of IDU [27,28,37,40]. This is
supported by study results indicating that IS Team facilita-
tors utilized their existing knowledge of commonly occur-
ring unsafe injecting practices to identify mistakes made
by local IDU during preparation and administration of in-
jections. Based on their own experiences, facilitators were
able to adopt a pragmatic approach to discussing various
injection practices by identifying why each step is import-
ant, potential consequences of unsafe practice, and
discussing the contextual factors that can make following
these steps difficult, as well as the strategies that can be
used to address them. Through their focus on common
barriers to safer injecting and navigating common situa-
tions experienced by local IDU, the IS Team campaign
not only expands the reach of safer injecting education,
but also incorporates novel elements which are not cur-
rently available elsewhere. Furthermore, examinations of
peer-driven interventions from other settings have shown
that IDU involvement provides built-in accommodation
to the cultural and ethnic diversity of the IDU population
by couching prevention and intervention messages in lo-
cally appropriate terms [28,52,53]. The results of this
study further these findings by showing that IS team facili-
tators were able to communicate and share information ina language accessible to workshop participants, and were
successful in drawing from their own experience to enable
discussions of the realities of participants’ injecting rituals.
Facilitators emphasized that this mutual understanding
minimized unequal power dynamics often existing be-
tween educators and learners, which have been identified
by other researchers as being counterproductive to educa-
tional goals [37,52].
Previous research has found that peer involvement in
prevention and advocacy work leads to positive identity
and pro-social role development, engendering a sense of
purpose and self-respect among IDU, which contrasts
the stigma often imposed on them by society [40,53,54].
The present study supports these findings as most facili-
tators reported developing social and professional skills
as a result of their involvement in IS Team workshops.
Furthermore, many facilitators described the positive
feelings they gained from realizing that they were mak-
ing a difference in their community by helping people to
protect their health. This is consistent with research on
motivation among peer workers showing that concern
for one’s own community and gaining satisfaction from
helping others are major motivators for conducting peer
prevention work [27,53]. Facilitators also reported im-
proving their own injection practices following the IS
Team education campaign. This is consistent with exam-
inations of peer leaders within larger social network in-
terventions showing that peers involved in education
and outreach report the greatest reductions in injection
risk behaviours after a follow-up period [27,28,30,53,54].
The results of this study suggest that employing non-
users in prevention and intervention work restricts IDU
from receiving the aforementioned benefits of this type
of work, while evidence indicates that they may in fact
be the most suitable candidates to deliver educational
messages.
Results of the present study indicate that the IS Team
education campaign provided participants with culturally
appropriate safer injecting education that addressed is-
sues relevant to local IDU. In this way, the IS Team con-
tinues a tradition of education and support programs at
VANDU that meet the immediate needs of IDU locally
[40,41,43]. This is consistent with research on the harm
reduction and prevention activities of user groups and
IDU in other settings demonstrating that IDU are cap-
able of active participation in their individual and col-
lective health and often develop novel interventions that
extend the range of existing services [38-41,51,55]. Facil-
itators’ experiences in this campaign also raised a few
practical considerations for the development and
delivery of these types of programs in the future. First,
facilitator’s participation was frequently impacted by in-
stabilities such as illness and competing priorities, which
are common in the lives of IDU, and must be planned
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mentation of user-led projects. Other VANDU programs
have addressed this issue by training multiple individuals
for each role within a program, then arranging for these
individuals to fill in for one another if someone misses
their appointed duty. Second, although the facilitators
spend a large amount of time on curriculum develop-
ment, there was a greater need to develop their present-
ing skills before starting the campaign, and workshops
involving detailed medical information would have bene-
fited from the addition of a professional educator such
as a nurse. Overall, the findings of this study indicate
that greater efforts are needed to support existing user-
led initiatives and to promote their growth and develop-
ment as a means of providing education and services to
IDU. Furthermore, health authorities and service pro-
viders developing services for IDU should incorporate
the perspectives of IDU in service development and
implementation to improve the relevance and cultural
appropriateness of these services.
The present study has a number of limitations. First,
the study focused exclusively on the perspective of indi-
viduals who were directly involved in the development
and facilitation of IS Team education workshops. As
such, the views presented by IS Team members may not
be representative of the experiences of IDU involved in
other interventions. Second, the perspective of one of the
initial IS Team members was not captured because he
withdrew from the team early in the development phase
of this education campaign. This member withdrew to
pursue another employment opportunity, although we
have no reason to believe that his perspective would have
been inconsistent with that of the remaining team mem-
bers. Third, although IS Team members were told that
their identity would be kept confidential and were encour-
aged to provide open and honest feedback on their partici-
pation, some participants may have been inclined to
provide overly positive evaluations given their association
with the campaign. However, an overly positive evaluation
does not appear to be reflected in the findings, as facilita-
tors provided numerous critiques of their own efforts and
expressed a desire to improve and expand their existing
activities to address additional issues facing local IDU.
Finally, this study sought the feedback and impressions of
workshop facilitators, yet it is also important to evaluate
the perspective of the recipients of this education. While
these data have been collected, we have elected to focus
here on the experiences of facilitators and will present the
findings related to the perspectives of recipients in a
separate manuscript.
In conclusion, this study demonstrates the feasibility
of involving IDU in educational initiatives targeting un-
safe injecting. Our findings demonstrate that involving
IDU in prevention activities improves relevance andcultural appropriateness of interventions while providing
individual, social, and professional benefits to IDU dir-
ectly involved in development and implementation of
such interventions.
Endnotes
1 Given that varied forms of pharmaceuticals require
different preparation procedures, specific information
was provided on how to prepare morphine eslon cap-
sules, morphine kadian capsules, hydromorphone, talwin
and ritalin, and methadone for injection.
Abbreviations
IDU: People who inject drugs; VANDU: Vancouver area network of drug
users; IS Team: Injection support team; DTES: Downtown eastside.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TK, WS, and CC conceived and designed the study. CC collaborated with the
IS Team, attended all planning and development meetings related to the
education campaign, observed all education campaign workshops,
conducted all interviews, and actively sought team member’s opinions and
feedback on research process. CC coded and analysed transcripts with input
from IS Team members. RA assisted with analysis and interpretation of the
data. TK and CC prepared the first draft of the manuscript. GC and WS
assisted with the main content and provided critical comments on the final
draft. All authors have read and approved the final version submitted for
publication.
Acknowledgements
We would particularly like to thank the IS Team for their time, participation,
and ongoing collaboration on this project. We would also like to thank the
research and administrative staff at the B.C. Centre for Excellence in HIV/AIDS
for their research assistance. Special thanks are due to Nicole Latham, Brian
O’Neill, Kate Shannon, Caitlin Johnston, Andrea Krusi, Danya Fast, and Terry
Howard. This study was supported by community-based research [CBR-
79873] and qualitative [MOP-81171] grants from the Canadian Institutes for
Health Research. Cody Callon is the recipient of a Canadian Institutes of
Health Research HIV/AIDS Community-Based Research Award. Thomas Kerr is
supported by the Canadian Institutes for Health Research and the Michael
Smith Foundation for Health Research.
Author details
1British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608-
1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada. 2School of Social Work,
University of British Columbia, 2080 West Mall, Vancouver, BC V6T 1Z2,
Canada. 3Department of Medicine, Faculty of Medicine, University of British
Columbia, 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
4Vancouver Area Network of Drug Users, 380 East Hastings Street, Vancouver,
BC V6A 1P4, Canada.
Received: 9 March 2012 Accepted: 25 February 2013
Published: 6 March 2013
References
1. Webb L, Oyefeso A, Schifano F, Cheeta S, Pollard M, Ghodse AH: Cause and
manner of death in drug-related fatality: an analysis of drug-related
deaths recorded by coroners in england and wales in 2000. Drug Alcohol
Depend 2003, 72:67–74.
2. Darke S, Hall W: Heroin overdose: research and evidence-based
intervention. J Urban Health 2003, 80:189–200.
3. HIV Prevention among injecting drug users. http://data.unaids.org/pub/
InformationNote/2009/20090518_hiv_prevention_among_idus_final_en.pdf.
4. Copeland L, Budd J, Robertson JR, Elton RA: Changing patterns in causes
of death in a cohort of injecting drug users, 1980–2001. Arch Intern Med
2004, 164:1214–1220.
Callon et al. Harm Reduction Journal 2013, 10:4 Page 9 of 10
http://www.harmreductionjournal.com/content/10/1/45. Hulse GK, English DR, Milne E, Holman CDJ: The quantification of mortality
resulting from the regular use of illicit opiates. Addiction 1999, 94:221–229.
6. Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection
among injecting drug users. Int J Drug Policy 2007, 18:352–358.
7. Gordon RJ, Lowy FD: Bacterial infections in drug users. N Engl J Med 2005,
353:1945–1954.
8. Grund JP: The eye of the needle: an ethno-epidemiological analysis of
injecting drug use. In Injecting illicit drugs. Edited by Pates R, McBride A,
Arnold K. Malden: Blackwell Publishing Inc; 2005:11–32.
9. Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection drug use: an understudied
cause of venous disease. Arch Dermatol 2007, 143:1305–1309.
10. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers
B, Ambekar A, Strathdee SA: HIV prevention, treatment, and care services
for people who inject drugs: a systematic review of global, regional, and
national coverage. Lancet 2010, 375:1014–1028.
11. Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR:
Persistence and change in disparities in HIV infection among injection
drug users in New york city after large-scale syringe exchange programs.
Am J Public Health 2009, 99:S445–S451.
12. Wodak A, Cooney A: Do needle syringe programs reduce HIV infection
among injecting drug users: a comprehensive review of the
international evidence. Subst Use Misuse 2006, 41:777–813.
13. Needle RH, Burrows D, Friedman SR, Dorabjee J, Touze G, Badrieva L,
Grund JPC, Kumar MS, Nigro L, Manning G, Latkin C: Effectiveness of
community-based outreach in preventing HIV/AIDS among injecting
drug users. Int J Drug Policy 2005, 16:S45–S57.
14. Coyle SL, Needle RH, Normand J: Outreach-based HIV prevention for
injecting drug users: a review of published outcome data. Public Health
Rep 1998, 113(Suppl 1):19–30.
15. Hedrich D: European report on drug consumption rooms. http://www.
centromedicinapreventiva.org/comunicazioni/news/ven2203045.pdf.
16. Kaldor J, Lapsley H, Mattick RP, Weatherburn D, Wilson A: Final report of the
evaluation of the sydney medically supervised injecting centre. http://www.
indro-online.de/sydneyfinalreport.pdf.
17. Kerr T, Kimber J, Debeck K, Wood E: The role of safer injection facilities in
the response to HIV/AIDS among injection drug users. Curr HIV/AIDS Rep
2007, 4:158–164.
18. Zule WA, Costenbader EC, Coomes CM, Wechsberg WM: Effects of a
hepatitis C virus educational intervention or a motivational intervention
on alcohol use, injection drug use, and sexual risk behaviors among
injection drug users. Am J Public Health 2009, 99(Suppl 1):S180–186.
19. Purcell DW, Garfein RS, Latka MH, Thiede H, Hudson S, Bonner S, Golub ET,
Ouellet LJ: Development, description, and acceptability of a small-group,
behavioral intervention to prevent HIV and hepatitis C virus infections
among young adult injection drug users. Drug Alcohol Depend 2007,
91(Suppl 1):S73–80.
20. Abou-Saleh M, Davis P, Rice P, Checinski K, Drummond C, Maxwell D,
Godfrey C, John C, Corrin B, Tibbs C, Oyefeso A, de Ruiter M, Ghodse H: The
effectiveness of behavioural interventions in the primary prevention of
hepatitis C amongst injecting drug users: a randomised controlled trial
and lessons learned. Harm Reduct J 2008, 5:25.
21. Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM,
Kapadia F, Garfein RS: Prevalence and correlates of indirect sharing
practices among young adult injection drug users in five U.S. Cities.
Drug Alcohol Depend 2007, 91(Suppl 1):S39–47.
22. Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M:
Hepatitis-associated knowledge is low and risks are high among HIV-aware
injection drug users in three US cities. Addiction 2002, 97:1277–1287.
23. Fairbairn N, Small W, Van Borek N, Wood E, Kerr T: Social structural factors
that shape assisted injecting practices among injection drug users in
vancouver, Canada: a qualitative study. Harm Reduct J 2010, 7:20.
24. Debeck K, Small W, Wood E, Li K, Montaner J, Kerr T: Public injecting
among a cohort of injection drug users in vancouver, canada. J Epidemiol
Community Health 2008, 63:81–86.
25. Rachlis B, Lloyd-Smith E, Small W, Tobin D, Stone D, Li K, Wood E, Kerr T:
Harmful microinjecting practices among a cohort of injection drug users
in vancouver canada. Subst Use Misuse 2010, 45:1351–1366.
26. Hoda Z, Kerr T, Li K, Montaner JSG, Wood E: Prevalence and correlates of
jugular injections among injection drug users. Drug Alcohol Rev 2008,
27:442–446.27. Latkin CA: Outreach in natural settings: the use of peer leaders for HIV
prevention among injecting drug users’ networks. Public Health Rep 1998,
113(Suppl 1):151–159.
28. Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ,
Hughes J: Harnessing peer networks as an instrument for AIDS prevention:
results from a peer-driven intervention. Public Health Rep 1998,
113(Suppl 1):42–57.
29. Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S: Use of a
peer leader intervention model to reduce needle-related risk behaviors
among drug injectors in ukraine. J Drug Issues 2009, 39:607–625.
30. Weeks MR, Li J, Dickson-Gomez J, Convey M, Martinez M, Radda K, Clair S:
Outcomes of a peer HIV prevention program with injection drug and
crack users: the risk avoidance partnership. Subst Use Misuse 2009,
44:253–281.
31. Broadhead R, Hammett TM, Kling R, Ngu D, Liu W, Chen Y, Ngoc Quyen H,
Thanh Binh K, Van Tren H, Borch C, Gauchat G, Des Jarlais DC: Peer-driven
interventions in vietnam and china to prevent HIV: a pilot study
targeting injection drug users. J Drug Issues 2009, 39:829–850.
32. Broadhead RS, Volkanevsky VL, Rydanova T, Ryabkova M, Borch C, van Hulst
Y, Fullerton A, Sergeyev B, Heckathorn DD: Peer-driven HIV interventions
for drug injectors in russia: first year impact results of a field experiment.
Int J Drug Policy 2006, 17:379–392.
33. Dickson-Gomez J, Weeks M, Martinez M, Convey M: Times and places:
process evaluation of a peer-led HIV prevention intervention. Subst Use
Misuse 2006, 41:669–690.
34. Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M:
Reaching the unreached: targeting hidden IDU populations with clean
needles via known user groups. J Psychoactive Drugs 1992, 24:41–47.
35. Carruthers S: The organization of a community: community-based
prevention of injecting drug use-related health problems. Subst Use
Misuse 2007, 42:1971–1977.
36. Crofts N, Herkt D: A history of peer-based drug-user groups in australia.
J Drug Issues 1995, 25:599–616.
37. Trautmann F: Peer support as a method of risk reduction in injecting
drug-user communities: experiences in dutch projects and the
“european peer support project”. J Drug Issues 1995, 25:617–628.
38. Friedman SR, de Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais DC,
Elovich R: Harm reduction theory: users’ culture, micro-social indigenous
harm reduction, and the self-organization and outside-organizing of
users’ groups. Int J Drug Policy 2007, 18:107–117.
39. Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R, Wood E:
Expanding the reach of harm reduction in thailand: experiences with a
drug user-run drop-in centre. Int J Drug Policy 2010, 21:255–258.
40. Kerr T, Small W, Peeace W, Douglas D, Pierre A, Wood E: Harm reduction
by a “user-run” organization: a case study of the vancouver area
network of drug users (VANDU). Int J Drug Policy 2006, 17:61–69.
41. Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E: A description of a
peer-run supervised injection site for injection drug users. J Urban Health
2005, 82:267–275.
42. Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O’Shaughnessy MV,
Schechter MT: An external evaluation of a peer-run “unsanctioned”
syringe exchange program. J Urban Health 2003, 80:455–464.
43. Hayashi K, Wood E, Wiebe L, Qi J, Kerr T: An external evaluation of a
peer-run outreach-based syringe exchange in vancouver, canada. Int J
Drug Policy 2010, 21:418–421.
44. Freire P: Pedagogy of the oppressed. 30th edition. New York: Continuum;
2000.
45. Sauve VL: From one educator to another: a window on participatory
education. Edmonton: Grant MacEwan Community College; 1987.
46. Harris GE: Practicing HIV/AIDS community-based research. AIDS Care 2006,
18:731–738.
47. Harper GW, Salina DD: Building collaborative partnerships to improve
community-based HIV prevention research. J Prev Interv Community 2000,
19:1–20.
48. Sandelowski M: Focus on research methods: whatever happened to
qualitative description? Res Nurs Health 2000, 23:334–340.
49. Glaser B, Strauss A: The discovery of grounded theory: strategies for qualitative
research. New York: Aldine De Gruyter; 1967.
50. Corbin J, Strauss A: Basics of qualitative research. 3rd edition. Los Angeles:
Sage; 2008.
Callon et al. Harm Reduction Journal 2013, 10:4 Page 10 of 10
http://www.harmreductionjournal.com/content/10/1/451. Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus
A: Urging others to be healthy: “intravention” by injection drug users as
a community prevention goal. AIDS Educ Prev 2004, 16:250–263.
52. Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL: Drug users
versus outreach workers in combating AIDS: preliminary results of a
peer-driven intervention. J Drug Issues 1995, 25:531–564.
53. Convey MR, Dickson-Gomez J, Weeks MR, Li J: Altruism and peer-led HIV
prevention targeting heroin and cocaine users. Qual Health Res 2010,
20:1546–1557.
54. Latkin CA, Sherman S, Knowlton A: HIV prevention among drug users:
outcome of a network-oriented peer outreach intervention. Health
Psychol 2003, 22:332–339.
55. Friedman SR, Des Jarlais DC, Sotheran JL, Garber J, Cohen H, Smith D: AIDS
and self-organization among intravenous drug users. Int J Addict 1987,
22:201–219.
doi:10.1186/1477-7517-10-4
Cite this article as: Callon et al.: ‘On the same level’: facilitators’
experiences running a drug user-led safer injecting education
campaign. Harm Reduction Journal 2013 10:4.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
